NIFTY 50 23203.2 ▼ (0.47%)
NIFTY NEXT 50 65053.6 ▲ (0.76%)
NIFTY 100 23926 ▼ (0.24%)
NIFTY MIDCAP 100 54607.65 ▲ (0.23%)
NIFTY SMALLCAP 100 17672.05 ▲ (0.16%)
NIFTY SMALLCAP 250 16700.5 ▼ (0.04%)
NIFTY MIDCAP SELECT 12249.85 ▲ (0.26%)
NIFTY TOTAL MARKET 12230.75 ▼ (0.15%)
NIFTY BANK 48540.6 ▼ (1.5%)
SENSEX 76619.33 ▼ (0.55%)
BSE BANKEX 54919.15 ▼ (1.83%)

Shareholding Pattern: Shareholding Pattern Krebs Biochemicals & Industries Ltd. An Examination of Financial Performance for FY (Q4-Mar 2023-2024)

Image is loading
Krebs Biochemicals & Industries Ltd. has unveiled its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q4-Mar 2023-2024).This comprehensive report offers a deep dive into the company’s shareholding landscape, including details on Promoters, promoter groups, Foreign investors, public investors, and government entities. Through meticulous comparative analysis, it tracks the evolution of shareholding percentages and quantities, highlighting any shifts in ownership dynamics. Investors gain invaluable insights into the company’s ownership structure and the evolving investment landscape.
Shareholder Name Previous Quater Quantity(In Crores) Current Quater Quantity(In Crores) Previous Quater Shares(in %) Current Quater Shares(in %) Quater to Quater Difference
Promoters 1.57 1.57 72.74 72.74 0
Public 0.59 0.59 26.76 26.76 0
DII 0 0 0 0 0
FII 0.01 0.01 0.5 0.5 0
Government 0.00 0.00 0 0 0
Promoters shareholding remained stable, at 72.74% in both December 2023 and March 2024. This indicates that the promoters’ control over the company did not change during this period. Public shareholding remained consistent, holding steady at 26.76% in both December 2023 and March 2024. This indicates that the Public control over the company did not change during this period. FIIs (Foreign Institutional Investors) shareholding remained at 0.5% from December 2023 to March 2024. , indicating no change in the investment levels by foreign institutions in the company. During quater from December 2023 to March 2024, Goverenment ownership remained steady at 0%.This indicates that the government’s stake in the company remained consistent during this period.

Let’s delve deeper into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.

Shareholder Name Previous Quarter Quantity (In Crores) Current Quarter Quantity (In Crores) Previous Quater Shares (in %) Current Quater Shares (in %) Quater-to-Quater Difference (%)
Directors and their relatives (excluding independent directors and nominee directors) 0.014 0.000 0.67 0 -0.67 %
Resident Individuals holding nominal share capital up to Rs. 2 lakhs 0.265 0.280 12.31 12.97 + 0.66 %
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs 0.130 0.154 6.03 7.13 + 1.1 %
Non Resident Indians (NRIs) 0.035 0.019 1.61 0.87 -0.74 %
Bodies Corporate 0.118 0.111 5.49 5.13 -0.36 %
Any Other (specify) 0.014 0.014 0.66 0.65 -0.01 %
HUF 0.014 0.014 0.66 0.65 -0.01 %
Observations indicate a sizeable -0.67 % variance in Directors and their relatives (excluding independent directors and nominee directors)’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Spearheading a savvy charge towards increased profitability, Resident Individuals holding nominal share capital up to Rs. 2 lakhs lifts the bar with a remarkable 0.66 % enhancement in net profit, revealing adroit resource allocation and sharpened commercial instincts.Spearheading a savvy charge towards increased profitability, Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs lifts the bar with a remarkable 1.1 % enhancement in net profit, revealing adroit resource allocation and sharpened commercial instincts.Observations indicate a sizeable -0.74 % variance in Non Resident Indians (NRIs)’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.36 % variance in Bodies Corporate’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.01 % variance in Any Other (specify)’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.01 % variance in HUF’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.
[my_shortcode1 values=”Krebs Biochemicals & Industries Ltd. “]

Related Post